Scientific and Clinical Advisory Board First member(s) to be announced in July 2018
Other Advisors:
William Gannon, MD, Chief Regulatory Officer
?Numerous managerial experience with multinational CROs, biotech and pharmaceutical companies, primarily cancer ?Substantial regulatory submissions and execution of Phase I through Phase IV both US and international
Anil Sood, MD
?Professor & Director, Blanton-Davis Ovarian Cancer Research Program, MD Anderson Cancer Center ?Discovered Prolanta’s mechanism of action (Autophagy)
?Preclinical efficacy and biomarker evaluation of Prolanta
My posts are my opinion and should not be used as investment advice. Make your own due diligence and decisions in your stock trades. GLTA